Hirudoid 0.3% cream

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)

العنصر النشط:

Heparinoid

متاح من:

Thornton & Ross Ltd

ATC رمز:

C05BA01

INN (الاسم الدولي):

Heparinoid

جرعة:

3mg/1gram

الشكل الصيدلاني:

Cutaneous cream

طريقة التعاطي:

Cutaneous

الفئة:

No Controlled Drug Status

نوع الوصفة الطبية :

Valid as a prescribable product

ملخص المنتج:

BNF: 13140000; GTIN: 5030451003348

نشرة المعلومات

GEN/HRDCM/PIL/272_07
23/01/2015
9240372 1411 GB
25192301
PACKAGE LEAFLET: INFORMATION FOR THE USER
HIRUDOID CREAM
HEPARINOID 0.3% W/W
READ ALL
OF
THIS LEAFLET
CAREFULLY BEFORE YOU START
USING THIS MEDICINE BECAUSE IT
CONTAINS
IMPORTANT INFORMATION FOR YOU.
Always use this medicine exactly as described in this leaflet or as
your doctor or pharmacist has told you.
-
Keep this leaflet. You may need to read it again.
-
Ask your pharmacist if you need more information or advice.
-
If you get any side-effects, talk to your doctor or pharmacist. This
includes any possible side-effects
not listed in this leaflet. See section 4.
-
You must talk to a doctor if your signs of illness or injury do not
improve.
WHAT IS IN THIS LEAFLET:
1. What Hirudoid Cream is and what it is used for
2. What you need to know before you use Hirudoid Cream
3. How to use Hirudoid Cream
4. Possible side-effects
5. How to store Hirudoid Cream
6. Contents of the pack and other information
1.WHAT HIRUDOID CREAM IS AND WHAT IT IS USED FOR
Hirudoid Cream contains the active substance heparinoid.
Hirudoid Cream is a local
anti-coagulant preparation which,
when applied to the skin,
relieves pain
and inflammation in addition to promoting healing in superficial
thrombophlebitis (inflammation of the
veins) and bruising (including haematoma).
2.WHAT YOU NEED TO KNOW BEFORE YOU USE HIRUDOID CREAM
DO NOT USE HIRUDOID CREAM:
• if you are allergic (hypersensitive)
to heparinoid or any of the other ingredients of Hirudoid Cream
(listed in section 6)
• if you have broken skin, or on large areas of skin
• on or near sensitive areas such as the mouth, eyes or ano-genital
regions.
Hirudoid Cream should NOT be used on children under the age of 5 years
old.
WARNINGS AND PRECAUTIONS
-
Hirudoid Cream is for external
use only. Do NOT swallow.
-
Do not exceed the dose stated in section 3.
-
Talk to your doctor if your signs of injury or illness do not improve
or get worse.
See section 4 for information about possible side-effects.
OTHER MEDICINES AND HIRUDOID CREAM

خصائص المنتج

OBJECT 1
HIRUDOID CREAM
Summary of Product Characteristics Updated 15-Apr-2015 | Genus
Pharmaceuticals
1. Name of the medicinal product
Hirudoid Cream
2. Qualitative and quantitative composition
Heparinoid 0.3% _wlw_ (Equivalent to 25 000 Units per 100 g cream).
3. Pharmaceutical form
Topical cream.
4. Clinical particulars
4.1 Therapeutic indications
Hirudoid is indicated for the treatment of superficial
thrombophlebitis and the soothing relief of
superficial bruising and haematoma.
4.2 Posology and method of administration
Adults, the elderly and children over 5 years of age:
Two to six inches (5-15 cm) to be applied up to four times daily to
the affected area and gently massaged
into the skin.
4.3 Contraindications
Not to be used on large areas of skin, broken skin, sensitive areas of
skin or mucous membranes. Not to
be used in individuals with a known sensitivity to any active or
inactive component of the formulation.
Not to be used in children under 5 years of age.
4.4 Special warnings and precautions for use
For external use only. If symptoms persist or worsen, seek medical
advice. Do not exceed the stated dose.
4.5 Interaction with other medicinal products and other forms of
interaction
None known.
4.6 Pregnancy and lactation
There is no evidence to suggest that Hirudoid should not be used
during pregnancy and lactation.
4.7 Effects on ability to drive and use machines
None.
4.8 Undesirable effects
None known.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the
medicinal product is important. It allows
continued monitoring of the benefit/risk balance of the medicinal
product. Healthcare professionals are
asked to report any suspected adverse reactions via the Yellow Card
Scheme at:
www.mhra.gov.uk/yellowcard
4.9 Overdose
In the absence of any reports of the accidental ingestion of Hirudoid,
no specific advice is available.
General supportive measures may be appropriate.
5. Pharmacological properties
5.1 Pharmacodynamic properties
Heparinoid is recognised